Cargando…
Redefining risk research priorities for nanomaterials
Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988212/ https://www.ncbi.nlm.nih.gov/pubmed/21170127 http://dx.doi.org/10.1007/s11051-009-9829-1 |
_version_ | 1782192235210604544 |
---|---|
author | Grieger, Khara D. Baun, Anders Owen, Richard |
author_facet | Grieger, Khara D. Baun, Anders Owen, Richard |
author_sort | Grieger, Khara D. |
collection | PubMed |
description | Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are largely directed at establishing (eco)toxicological and exposure data for NM, and comparatively little research has been undertaken on tools or approaches that may facilitate near-term decisions, some of which we briefly outline in this analysis. We propose a reprioritisation of NM risk research efforts to redress this imbalance, including the development of more adaptive risk governance frameworks, alternative/complementary tools to risk assessment, and health and environment surveillance. |
format | Text |
id | pubmed-2988212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-29882122010-12-15 Redefining risk research priorities for nanomaterials Grieger, Khara D. Baun, Anders Owen, Richard J Nanopart Res Perspectives Chemical-based risk assessment underpins the current approach to responsible development of nanomaterials (NM). It is now recognised, however, that this process may take decades, leaving decision makers with little support in the near term. Despite this, current and near future research efforts are largely directed at establishing (eco)toxicological and exposure data for NM, and comparatively little research has been undertaken on tools or approaches that may facilitate near-term decisions, some of which we briefly outline in this analysis. We propose a reprioritisation of NM risk research efforts to redress this imbalance, including the development of more adaptive risk governance frameworks, alternative/complementary tools to risk assessment, and health and environment surveillance. Springer Netherlands 2009-12-24 2010-02 /pmc/articles/PMC2988212/ /pubmed/21170127 http://dx.doi.org/10.1007/s11051-009-9829-1 Text en © Springer Science+Business Media B.V. 2009 |
spellingShingle | Perspectives Grieger, Khara D. Baun, Anders Owen, Richard Redefining risk research priorities for nanomaterials |
title | Redefining risk research priorities for nanomaterials |
title_full | Redefining risk research priorities for nanomaterials |
title_fullStr | Redefining risk research priorities for nanomaterials |
title_full_unstemmed | Redefining risk research priorities for nanomaterials |
title_short | Redefining risk research priorities for nanomaterials |
title_sort | redefining risk research priorities for nanomaterials |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988212/ https://www.ncbi.nlm.nih.gov/pubmed/21170127 http://dx.doi.org/10.1007/s11051-009-9829-1 |
work_keys_str_mv | AT griegerkharad redefiningriskresearchprioritiesfornanomaterials AT baunanders redefiningriskresearchprioritiesfornanomaterials AT owenrichard redefiningriskresearchprioritiesfornanomaterials |